DrugPatentWatch Database Preview
Thrombogenics, Inc Company Profile
Summary for Thrombogenics, Inc
| Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| BLAs: | 1 |
US Patents for Thrombogenics, Inc
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 9,730,888 | Wayne State University (Detroit, MI) | ➤ Sign Up | RX | search | |
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 9,603,739 | OcuJect, LLC (Newport Beach, CA) | ➤ Sign Up | RX | search | |
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 9,504,603 | OcuJect, LLC (Newport Beach, CA) | ➤ Sign Up | RX | search | |
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 9,474,688 | Corning Incorporated (Corning, NY) | ➤ Sign Up | RX | search | |
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 9,421,129 | OcuJect, LLC (Newport Beach, CA) | ➤ Sign Up | RX | search | |
| Thrombogenics, Inc | JETREA | ocriplasmin | INJECTABLE; INTRAVITREAL | 125422 | 001 | 2012-10-17 | 7,914,783 | ThromboGenics NV (Heverlee, BE) | ➤ Sign Up | RX | company | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
